Catalyst Event
Celltrion Inc (068270) · Other
From Akros Korea Shareholder Return High Dividend Index (AKSRHD)
6/1/2026, 12:00:00 AM
Announced the submission of a marketing authorization application to Health Canada for CT-P55, a biosimilar to the autoimmune disease treatment Cosentyx.
Korean Translation
자가면역질환 치료제 코센틱스의 바이오시밀러 'CT-P55'에 대해 캐나다 보건부에 품목허가를 신청했다고 발표함.
Related Recent Events
Woori Financial Group Inc (316140) · Trading Issue
Board resolution on 2026-04-24 to acquire the remaining shares of Tongyang Life Insurance through a comprehensive stock swap and make it a wholly owned subsidiary, with 8,696,875 new Woori Financial common shares to be issued.
8/31/2026, 12:00:00 AM
LX International Corp (001120) · Earnings Release
Q2 2026 earnings release, with low importance estimated for a routine announcement, scheduled.
8/18/2026, 12:00:00 AM
Cheil Communications Inc (030000) · Earnings Release
Low importance estimated as it is a routine announcement; Q2 2026 earnings release scheduled.
8/17/2026, 12:00:00 AM
Kepco Plant Service & Engineering Co Ltd (051600) · Earnings Release
2Q 2026 earnings release is scheduled; this is expected to have a 1-5% price impact.
8/14/2026, 12:00:00 AM
Daishin Securities Co Ltd (003540) · Earnings Release
Daishin Securities' Q2 2026 earnings release is scheduled. Low importance estimated as the announcement date itself typically has minimal market impact.
8/7/2026, 12:00:00 AM
Shin Young Securities Co Ltd (001720) · Other
Annual general meeting on 2026-06-19 to decide on the handling of its treasury shares (over 51% of total stock) following a commercial law revision; high impact expected as the decision could significantly improve shareholder value, scheduled.
6/19/2026, 12:00:00 AM